Disclaimer stocks involve risks, do research before investing. most tweets are paid advertisement we have been paid. stockverse.com/disclaimer
Joined September 2023
- Tweets 975
- Following 6,188
- Followers 2,865
- Likes 5,412
79 Photos and videos
StockVerse retweeted
Jun 16
Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044 stockverse.com/news/oncolyti…
$oncy
1
2
68
Jun 16
Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044 stockverse.com/news/oncolyti…
$oncy
1
2
68
StockVerse retweeted
Jun 16
2
3
86
Jun 16
Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044 stockverse.com/news/oncolyti…
$oncy
1
3
63
Jun 16
$ONCY Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044 globenewswire.com/news-relea…
1
2
78
Jun 15
4
94
Jun 15
$COSM Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit globenewswire.com/news-relea…
169
Jun 12
$COSM “These orders reflect the demand for Cana's contract manufacturing capabilities and the strength of our vertically integrated platform. By deepening our…” globenewswire.com/news-relea…
1
106
Jun 12
1
2
91
Jun 12
$COSM Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit stockverse.com/news/cosmos-h…
1
2
90
Jun 11
$COSM Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance stockverse.com/news/cosmos-h…
1
3
97
Jun 11
$COSM Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance
stocktitan.net/news/COSM/cos…
2
109